Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Maria Bach Laursen"'
Autor:
Line Dahl Jeppesen, Lotte Hatt, Ripudaman Singh, Palle Schelde, Katarina Ravn, Christian Liebst Toft, Maria Bach Laursen, Jakob Hedegaard, Inga Baasch Christensen, Bolette Hestbek Nicolaisen, Lotte Andreasen, Lars Henning Pedersen, Ida Vogel, Dorte Launholt Lildballe
Publikováno v:
Frontiers in Genetics, Vol 14 (2023)
Introduction: Circulating fetal cells isolated from maternal blood can be used for prenatal testing, representing a safe alternative to invasive testing. The present study investigated the potential of cell-based noninvasive prenatal testing (NIPT) f
Externí odkaz:
https://doaj.org/article/1de434c9e29148f39b2d71fd2aed3f72
Autor:
Amanda Frydendahl Boll Johansen, Christine Gaasdal Kassentoft, Michael Knudsen, Maria Bach Laursen, Anders Husted Madsen, Lene Hjerrild Iversen, Kåre Gotschalck Sunesen, Mads Heilskov Rasmussen, Claus Lindbjerg Andersen
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-8 (2019)
Abstract Background Microsatellite instability (MSI), resulting from a defective mismatch repair system, occurs in approximately 15% of sporadic colorectal cancers (CRC). Since MSI is associated with a poor response to 5-fluorouracile based chemother
Externí odkaz:
https://doaj.org/article/90060eda57db48bc8f45e239d40eccb9
Autor:
Benyamin Ranjbar, Louise Bechmann Krogh, Maria Bach Laursen, Maria Nascimento Primo, Sara Correia Marques, Karen Dybkær, Jacob Giehm Mikkelsen
Publikováno v:
PLoS ONE, Vol 11, Iss 4, p e0153069 (2016)
Diffuse large B-cell lymphoma (DLBCL) is characterized by great genetic and clinical heterogeneity which complicates prognostic prediction and influences treatment efficacy. The most common regimen, R-CHOP, consists of a combination of anthracycline-
Externí odkaz:
https://doaj.org/article/b6092941c80540d19e24d720a0c92118
Autor:
Ditte Starberg Jespersen, Julie Støve Bødker, Steffen Falgreen, Suzette Sørensen, Hans Erik Johnsen, Maria Bach Laursen, Martin Bøgsted, Karen Dybkær, Anna Amanda Schönherz, Linn Reinholdt, Hanne Due, Marianne Schmidt Ettrup, Rasmus Røge, Alexander Schmitz, Lykke Christina Grubach
Publikováno v:
Laursen, M B, Reinholdt, L, Schönherz, A A, Due, H, Jespersen, D S, Grubach, L, Ettrup, M S, Røge, R, Falgreen, S, Sørensen, S, Bødker, J S, Schmitz, A, Johnsen, H E, Bøgsted, M & Dybkær, K 2019, ' High CXCR4 expression impairs rituximab response and the prognosis of R-CHOP-treated diffuse large B-cell lymphoma patients ', Oncotarget, vol. 10, no. 7, pp. 717-731 . https://doi.org/10.18632/oncotarget.26588
Laursen, M B, Reinholdt, L, Schönherz, A A, Due, H, Jespersen, D S, Grubach, L, Ettrup, M S, Røge, R, Falgreen, S, Sørensen, S, Bødker, J S, Schmitz, A, Johnsen, H E, Bøgsted, M & Dybkær, K 2019, ' High CXCR4 expression impairs rituximab response and the prognosis of R-CHOP-treated diffuse large B-cell lymphoma patients ' OncoTarget, vol. 10, no. 7, pp. 717-731 . https://doi.org/10.18632/oncotarget.26588
Oncotarget
Laursen, M B, Reinholdt, L, Schönherz, A A, Due, H, Jespersen, D S, Grubach, L, Ettrup, M S, Røge, R, Falgreen, S, Sørensen, S, Bødker, J S, Schmitz, A, Johnsen, H E, Bøgsted, M & Dybkær, K 2019, ' High CXCR4 expression impairs rituximab response and the prognosis of R-CHOP-treated diffuse large B-cell lymphoma patients ' OncoTarget, vol. 10, no. 7, pp. 717-731 . https://doi.org/10.18632/oncotarget.26588
Oncotarget
Survival of diffuse large B-cell lymphoma (DLBCL) patients has improved by inclusion of rituximab. Refractory/recurrent disease caused by treatment resistance is, however, a major problem. Determinants of rituximab sensitivity are not fully understoo
Autor:
Anders Husted Madsen, Maria Bach Laursen, Claus L. Andersen, Michael Knudsen, Kåre Gotschalck Sunesen, Amanda Frydendahl Boll Johansen, Mads Rasmussen, Lene Hjerrild Iversen, Christine Gaasdal Kassentoft
Publikováno v:
BMC Cancer
Johansen, A F B, Kassentoft, C G, Knudsen, M, Laursen, M B, Madsen, A H, Iversen, L H, Sunesen, K G, Rasmussen, M H & Andersen, C L 2019, ' Validation of computational determination of microsatellite status using whole exome sequencing data from colorectal cancer patients ', BMC Cancer, vol. 19, no. 1, 971 . https://doi.org/10.1186/s12885-019-6227-7
BMC Cancer, Vol 19, Iss 1, Pp 1-8 (2019)
Johansen, A F B, Kassentoft, C G, Knudsen, M, Laursen, M B, Madsen, A H, Iversen, L H, Sunesen, K G, Rasmussen, M H & Andersen, C L 2019, ' Validation of computational determination of microsatellite status using whole exome sequencing data from colorectal cancer patients ', BMC Cancer, vol. 19, no. 1, 971 . https://doi.org/10.1186/s12885-019-6227-7
BMC Cancer, Vol 19, Iss 1, Pp 1-8 (2019)
Background Microsatellite instability (MSI), resulting from a defective mismatch repair system, occurs in approximately 15% of sporadic colorectal cancers (CRC). Since MSI is associated with a poor response to 5-fluorouracile based chemotherapy and i
Autor:
Paw Jensen, Tarec Christoffer El-Galaly, Karen Dybkær, Pernille Svendsen, Maria Bach Laursen, Hans Erik Johnsen, Alexander Schmitz, Martin Bøgsted
Publikováno v:
Svendsen, P, El-Galaly, T C, Dybkær, K, Bøgsted, M, Laursen, M B, Schmitz, A, Jensen, P & Johnsen, H E 2015, ' The Application of Human Phase 0 Microdosing Trials : a Systematic Review and Perspectives ', Leukemia and Lymphoma, vol. 57, no. 6, pp. 1281-1290 . https://doi.org/10.3109/10428194.2015.1101097
Svendsen, P, El-Galaly, T C, Dybkær, K, Bøgsted, M, Laursen, M B, Schmitz, A, Jensen, P & Johnsen, H E 2016, ' The application of human phase 0 microdosing trials : A systematic review and perspectives ', Leukemia and Lymphoma, vol. 57, no. 6, pp. 1281-1290 . https://doi.org/10.3109/10428194.2015.1101097
Svendsen, P, El-Galaly, T C, Dybkær, K, Bøgsted, M, Laursen, M B, Schmitz, A, Jensen, P & Johnsen, H E 2016, ' The application of human phase 0 microdosing trials : A systematic review and perspectives ', Leukemia and Lymphoma, vol. 57, no. 6, pp. 1281-1290 . https://doi.org/10.3109/10428194.2015.1101097
A decreasing number of new therapeutic drugs reaching the clinic has led to the publication of regulatory guidelines on human microdosing trials by the European Medicines Agency in 2004 and the U.S. Food and Drug Administration in 2006. Microdosing t
Autor:
Steffen Falgreen, Maria Bach Laursen, Rasmus Froberg Brøndum, Linn Reinholdt, Alexander Schmitz, Anna Amanda Schönherz, Martin Bøgsted, Karen Dybkær, Hanne Due, Marianne Tang Severinsen, Mette Nyegaard, Hans Erik Johnsen, Lasse Hjort Jakobsen, Tarec Christoffer El-Galaly, Julie Støve Bødker
Publikováno v:
Bødker, J S, Severinsen, M T, El-Galaly, T C, Brøndum, R F, Laursen, M B, Larsen, S F, Nyegaard, M, Schmitz, A, Jakobsen, L H, Schönherz, A A, Due, H, Reinholdt, L, Bøgsted, M, Dybkær, K & Johnsen, H E 2017, ' Molecular classification of tissue from a transformed non-Hogkin's lymphoma case with unexpected long-time remission ', Experimental Hematology & Oncology, vol. 6, 3 . https://doi.org/10.1186/s40164-016-0063-0
Experimental Hematology & Oncology
Experimental Hematology & Oncology
Background The concept of precision medicine in cancer includes individual molecular studies to predict clinical outcomes. In the present N = 1 case we retrospectively have analysed lymphoma tissue by exome sequencing and global gene expression in a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02807553a40a8bb1558878e8bda14af5
https://vbn.aau.dk/da/publications/c11d8826-a5a8-4d0c-abc4-a0965e879bd3
https://vbn.aau.dk/da/publications/c11d8826-a5a8-4d0c-abc4-a0965e879bd3
Autor:
Mette Østergaard Thunbo, Laura Krogh Herlin, Suzette Sørensen, Steffen Falgreen, Julie Støve Bødker, Maria Bach Laursen, Alexander Schmitz, Hans Erik Johnsen, Karen Dybkær, Martin Bøgsted
Publikováno v:
Poulsen, M Ø, Jørgensen, L T K, Sørensen, S, Larsen, S F, Bødker, J S, Laursen, M B, Schmitz, A, Johnsen, H E, Dybkær, K & Bøgsted, M 2016, ' Alternative pre-mRNA splicing leads to potential biomarkers in diffuse large B-cell lymphoma : a systematic review ', Danish Medical Journal, vol. 63, no. 3, A5206 . < http://www.danmedj.dk/portal/pls/portal/!PORTAL.wwpob_page.show?_docname=11167457.PDF >
Aarhus University
Aarhus University
INTRODUCTION: The study of potential biomarkers in haematological malignancies has gained momentum in past decades. We compiled a systematic review to outline potential biomarkers based on alternative pre-mRNA splicing that were suggested to be clini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::79f50408a812c730a4b58aa05d329dcf
https://vbn.aau.dk/da/publications/11a3c30a-68ce-49ed-b813-b269ffba0149
https://vbn.aau.dk/da/publications/11a3c30a-68ce-49ed-b813-b269ffba0149
Autor:
Chuanzheng Zhou, Dalibor Odadzic, Malgorzata Wenska, Torben Højland, Jens Haas, Jesper Wengel, Claus Bus, Maria Bach Laursen, Joachim W. Engels, Cordula Andree, Thomas F. Meyer, Puneet Srivastava, Simone Hess, Marino Zerial, Piet Herdewijn, Eugenio Fava, Jyoti Chattopadhyaya, Niels Langkjær, Elke Müller, Anne Færch Nielsen, Thomas B. Hansen, Mikhail Abramov, Romualdas Smicius, Dmytro Honcharenko, Georgii V. Bobkov, B. Ravindra Babu, Jesper B. Bramsen, Sergey N. Mikhailov, Jørgen Kjems, Arthur Van Aerschot, Jharna Barman
Publikováno v:
Nucleic Acids Research
Bramsen, J B, Laursen, M B, Nielsen, A F, Hansen, T B, Bus, C, Langkjær, N, Babu, B R, Hojland, T, Abramov, M, Van Aerschot, A, Odadzic, D, Smicius, R, Haas, J, Andree, C, Barman, J, Wenska, M, Srivastava, P, Zhou, C, Honcharenko, D, Hess, S, Hess, S, Bobkov, G V, Mikhailov, S N, Fava, E, Meyer, T F, Chattopadhyaya, J, Zerial, M, Engels, J W, Herdewijn, P, Wengel, J & Kjems, J 2009, ' A large-scale chemical modification screen identifies design rules to generate siRNAs with high activity, high stability and low toxicity ', Nucleic Acids Research, vol. 37, no. 9, pp. 2867-2881 . https://doi.org/10.1093/nar/gkp106
Bramsen, J B, Laursen, M B, Nielsen, A F, Hansen, T B, Bus, C, Langkjær, N, Babu, B R, Højland, T, Abramov, M, Van Aerschot, A, Odadzic, D, Smicius, R, Haas, J, Andree, C, Barman, J, Wenska, M, Srivastava, P, Zhou, C, Honcharenko, D, Hess, S, Müller, E, Bobkov, G V, Mikhailov, S N, Fava, E, Meyer, T F, Chattopadhyaya, J, Zerial, M, Engels, J W, Herdewijn, P, Wengel, J & Kjems, J 2009, ' A large-scale chemical modification screen identifies design rules to generate siRNAs with high activity, high stability and low toxicity ', Nucleic Acids Research, vol. 37, no. 9, pp. 2867-81 . https://doi.org/10.1093/nar/gkp106
Bramsen, J B, Laursen, M B, Nielsen, A F, Hansen, T B, Bus, C, Langkjær, N, Babu, B R, Hojland, T, Abramov, M, Van Aerschot, A, Odadzic, D, Smicius, R, Haas, J, Andree, C, Barman, J, Wenska, M, Srivastava, P, Zhou, C, Honcharenko, D, Hess, S, Hess, S, Bobkov, G V, Mikhailov, S N, Fava, E, Meyer, T F, Chattopadhyaya, J, Zerial, M, Engels, J W, Herdewijn, P, Wengel, J & Kjems, J 2009, ' A large-scale chemical modification screen identifies design rules to generate siRNAs with high activity, high stability and low toxicity ', Nucleic Acids Research, vol. 37, no. 9, pp. 2867-2881 . https://doi.org/10.1093/nar/gkp106
Bramsen, J B, Laursen, M B, Nielsen, A F, Hansen, T B, Bus, C, Langkjær, N, Babu, B R, Højland, T, Abramov, M, Van Aerschot, A, Odadzic, D, Smicius, R, Haas, J, Andree, C, Barman, J, Wenska, M, Srivastava, P, Zhou, C, Honcharenko, D, Hess, S, Müller, E, Bobkov, G V, Mikhailov, S N, Fava, E, Meyer, T F, Chattopadhyaya, J, Zerial, M, Engels, J W, Herdewijn, P, Wengel, J & Kjems, J 2009, ' A large-scale chemical modification screen identifies design rules to generate siRNAs with high activity, high stability and low toxicity ', Nucleic Acids Research, vol. 37, no. 9, pp. 2867-81 . https://doi.org/10.1093/nar/gkp106
The use of chemically synthesized short interfering RNAs (siRNAs) is currently the method of choice to manipulate gene expression in mammalian cell culture, yet improvements of siRNA design is expectably required for successful application in vivo. S
Autor:
Laura Krogh Herlin, Mette Østergaard Poulsen, Maria Bach Laursen, Sara Correia Marques, Johnsen, Hans E., Martin Bøgsted, Karen Dybkær
Publikováno v:
Jørgensen, L T K, Poulsen, M Ø, Laursen, M B, Marques, S C, Johnsen, H E, Bøgsted, M & Dybkær, K 2015, ' MicroRNAs as novel biomarkers in diffuse large B-cell lymphoma : a systematic review ', Danish Medical Journal, vol. 62, no. 5, A5048 . < http://www.danmedj.dk/portal/page/portal/danmedj.dk/dmj_forside/PAST_ISSUE/2015/DMJ_2015_05/A5048 >
Aarhus University
Jørgensen, L K, Poulsen, M Ø, Laursen, M B, Marques, S C, Johnsen, H E, Bøgsted, M & Dybkær, K 2014, ' MicroRNAs as novel biomarkers in diffuse large B-cell lymphoma--a systematic review ', Danish Medical Journal, vol. 62, no. 5 .
Aarhus University
Jørgensen, L K, Poulsen, M Ø, Laursen, M B, Marques, S C, Johnsen, H E, Bøgsted, M & Dybkær, K 2014, ' MicroRNAs as novel biomarkers in diffuse large B-cell lymphoma--a systematic review ', Danish Medical Journal, vol. 62, no. 5 .
Introduction: MicroRNAs (miRNAs) are short non-codingRNAs that have the ability to regulate gene expression atthe post-transcriptional level. MiRNAs are deregulated inmany cancer types, and several miRNAs have been suggestedas novel diagnostic and pr